Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE)) market cap declines to $ 6.0 billion, but insiders who sold $ 4.9 million shares were able to cover their losses

In the past year, insiders have sold for $ 4.9 million Ultragenyx Pharmaceuticals Inc. (NASDAQ: RARE) at an average price of $ 132 per share allowing them to get the most out of their money. The company’s market valuation fell by US $ 496 million after the stock price fell 7.7% over the past week, but insiders were spared painful losses.

While we never suggest that investors should base their decisions solely on what the directors of a company have done, we consider it foolish to ignore insider trading altogether.

Check out our latest review for Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical Insider Transactions in the Past Year

In the past twelve months, the biggest sale by an insider was when Director of Quality Operations and Executive Vice President of Translational Sciences John Pinion sold US $ 856,000 worth of shares for $ 138 US per share. We usually don’t like to see insider sales, but the lower the selling price, the more it concerns us. The positive side is that this drop took place above the last price (US $ 87.80). So it might not shed much light on insider confidence at current levels.

Ultragenyx Pharmaceutical insiders have not bought any shares in the past year. Below you can see a visual representation of insider trading (by businesses and individuals) over the past 12 months. If you click on the chart you can see all of the individual trades including the stock price, individual and date!

NasdaqGS: RARE Insider Trading Volume October 3, 2021

If you like to buy stocks that insiders buy rather than sell, then you might love this free list of companies. (Hint: insiders bought them).

Ultragenyx pharmaceutical insiders sell their shares

Over the past three months we’ve seen quite a bit of insider selling at Ultragenyx Pharmaceutical. Executive Vice President and Chief Commercial Officer Erik Harris only sold US $ 34,000 of shares during this period. Neither the lack of buying nor the presence of selling is encouraging. But the sale just isn’t big enough to be of much use as a signal.

Insider Property of Ultragenyx Pharmaceutical

Looking at the total insider stakes in a company can help you determine if they are aligned with common shareholders. I think it’s a good sign if the insiders own a significant number of shares in the company. It’s great to see Ultragenyx Pharmaceutical insiders own 4.8% of the company, worth around $ 286 million. This type of large insider ownership generally increases the chances that the business will be run in the best interests of all shareholders.

So what do Ultragenyx’s pharmaceutical insider trading indicate?

While there have been no insider buys in the past three months, there have been sales. However, sales are not important enough to be of concern to us at all. Encouragingly, insiders own a lot of stocks, but we would like to see more insider buying as the last year of Ultragenyx Pharmaceutical’s insider trading does not give us confidence. So these insider trading can help us build a stock thesis, but it’s also worth knowing the risks this business faces. For example – Ultragenyx Pharmaceutical has 2 warning signs we think you should be aware.

If you would rather consult with another company – one with potentially superior finances – then don’t miss this free list of interesting companies, which have a HIGH return on equity and low leverage.

For the purposes of this article, insiders are the persons who report their transactions to the relevant regulatory body. We currently account for open market transactions and private assignments, but not derivative transactions.

This Simply Wall St article is general in nature. We provide commentary based on historical data and analyst forecasts using only unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell shares and does not take into account your goals or your financial situation. Our aim is to bring you long-term, targeted analysis based on fundamental data. Note that our analysis may not take into account the latest announcements from price sensitive companies or qualitative documents. Simply Wall St has no position in any of the stocks mentioned.

Do you have any feedback on this item? Are you worried about the content? Get in touch with us directly. You can also send an email to the editorial team (at) simplywallst.com.

If you decide to trade Ultragenyx Pharmaceutical use the cheapest platform * which is ranked # 1 overall by Barron’s, Interactive brokers. Trade stocks, options, futures, currencies, bonds and funds in 135 markets, all from one integrated account.Promoted

Source link

Sulbactam market share to register robust growth until 2026

The recent study on the Sulbactam Market offers a comprehensive study of this business area, based on key growth drivers, opportunities, and restraints shaping the market dynamics. A database of regional markets alongside leading companies that have consolidated their positions in these geographies is described in the report. Additionally, it shines a light on the disruption caused by the COVID-19 pandemic and highlights popular business strategies used by key participants to adapt to the changing landscape.

Main highlights of the impact assessment of COVID-19:

  • Global footprint of the COVID-19 pandemic alongside its implications for the economy.
  • Uncertainties in the supply and demand channels.
  • Short-term and expected outlook of the COVID-19 pandemic on the growth trajectory.

An overview of the regional analysis:

  • Geographically, the Sulbactam market is segmented into North America, Europe, Asia-Pacific, South America, Middle East & Africa, South East Asia.
  • A synopsis of each geographic area, including their estimated growth rate during the forecast period, is attached to the report.
  • The total revenue and sales accrued by each regional contributor is cited.

Request a copy of this report @ https://www.nwdiamondnotes.com/request-sample/26440

Additional Highlights of the Sulbactam Market Report:

  • Based on the product line, the Sulbactam market is divided into Intravenous Injection, Intramuscular Injection, and others.
  • The revenue and volume estimates for each product segment during the forecast period are documented.
  • The scope of the Sulbactam market includes adults and children.
  • Information on the annual growth rate and market share of each application segment during the analysis period is also included.
  • The major players defining the competitive landscape of the Sulbactam market are Wuhan DKY Technology, Jiangsu Huaxu Pharmaceutical, Xinyou Chen, Fresenius Kabi, Shijiazhuang Zhongshuo Pharmaceutical, Vardhman Chem, Dawnrays Pharm, Jiangxi Huabang Pharmaceuticals, and MN Pharmaceuticals.
  • The detailed business portfolio of the listed organizations, including their product offerings, manufacturing facilities, production models and compensation, is incorporated into the document.
  • Other important business facets such as gross margins, pricing models and revenue share of each participant are systematically presented.
  • The paper explains competitive industry trends and provides a holistic study of the supply chain.
  • Using Porter’s five forces analysis and SWOT analysis, he asserts the feasibility of a new project.

Research methodology :

The report follows a comprehensive and rigorous research methodology to provide you with accurate estimates and forecasts of a particular market. The report provides estimates, forecasts, and analysis primarily based on secondary research, primary interviews, an internal database, and other free and paid sources. Furthermore, the research methodology we follow is a systematic approach to estimate and project the market size with all ongoing and upcoming market trends in mind.

Reasons to buy this report:

  • It offers an analysis of the evolution of the competitive scenario.
  • To make informed decisions in companies, it offers analytical data with strategic planning methodologies.
  • It offers a seven-year assessment of the global sulbactam market.
  • It helps to understand the main key product segments.
  • Researchers shed light on market dynamics such as drivers, restraints, trends, and opportunities.
  • It offers the regional analysis of the Global Sulbactam Market along with business profiles of several stakeholders.
  • It offers massive data about trending factors that will influence the progress of the Global Sulbactam Market.

The key questions answered in this report:

  • What will the market size and growth rate be during the forecast year?
  • What are the key factors driving the global Sulbactam market?
  • What are the risks and challenges facing the market?
  • Who are the main suppliers of the global Sulbactam market?
  • What are the trend factors influencing market shares?
  • What are the main results of Porter’s five forces model?
  • What are the global opportunities for developing the global Sulbactam market?

Important point mentioned in the Research report:

  • Market overview, market dynamics, market growth etc. are cited in the report.
  • The power and commercial output of major manufacturers have been mentioned along with the technical data.
  • The study provides historical market data with revenue forecast and forecast from 2020 to 2025.
  • This report is a valuable asset for existing players, new entrants and future investors.

Highlights from the Table of Contents of the Sulbactam market size study:

  • Market overview and summary

Request customization on this report @ https://www.nwdiamondnotes.com/request-for-customization/26440

Source link

Fall market | Laurier Magazine

Written by: Mary Jane McCall | Problem: 2021/10 – October

October brings the fruits of the fall harvest to the Highlands Marketplace, held every Saturday morning at Kelsey-Hutchinson Founders Park.


What could be more fun than jumping for apples?

Shop for apples at an outdoor farmers market on a cool fall morning, or chat with a local grower to see if he has the perfect apple pie recipe.

Highlands Marketplace is the perfect place to do this every Saturday morning from 8:00 a.m. to 12:30 p.m. at Kelsey Hutchinson Park on Pine Street.

Here you will not only find apples and everything apple related, but also the freshest in everything you need to complete your fall menu or decorating project.

Think of the freshest produce, meats, seafood, flowers, jams, jellies, pickles, relish, eggs, butter, dips, herbs and spices.

Not to mention the pastries that will make your mouth water and make your family and guests happy all weekend long.

These fall decorating projects will be a breeze as you choose from fresh fall flowers, plants, pumpkins, and crafts to complete your fall refreshment. That’s right, in addition to all the tasty food items, this perfect little farmers market also attracts local artisans and artists. In fact, you never know what you’ll find here from week to week, so make a habit of visiting on Saturday mornings.

We even go out on a branch and mention the C word, Christmas, that is. Who wouldn’t want a homemade gift or a Highland Christmas stocking? You can find a perfect gift and have an interesting story to tell about that perfect fall day when you find it. It’s best to share stories about shipping nightmares later in the season.

Don’t miss this, your last chance to visit the Highlands Marketplace and stock up on your favorite items before they close until spring.

Source link

Bitcoin Poke $ 48,000 As Crypto Market Cap Rises $ 170 Billion In One Day

For the first time since mid-September, the price of Bitcoin has climbed above $ 47,000 per day. The bullish news from the United States appears to be influencing the cryptocurrency market as Bitcoin topped $ 47,000 for the second time. On a daily basis, liquidations soared to nearly $ 400 million, with most alternative coins following suit.

Image source: Cryptopotato

The major cryptocurrency yesterday fell below $ 41,000 for the third time in less than a week. However, it quickly bounced back and soared to over $ 43,000. BTC remained stable for a while, but the situation changed again following a meeting in the United States when Fed Chairman Jerome Powell reaffirmed the government was not considering implementing a ban of cryptocurrency.

Markets reacted immediately, with BTC surging $ 2,000 to a weekly high of around $ 45,000. The asset’s daily gains didn’t stop there, however, as it began another dramatic surge in the hours that followed. It rose to $ 47,800 (on Bitstamp) this time, the highest price since September 20.

It’s not just Bitcoin, however. With huge double-digit gains, the rest of the cryptocurrencies have followed suit. Examples are Binance Coin, Solana, Polkadot, Uniswap, Chainlink and others.

Since yesterday’s low, Ethereum has recovered nearly $ 300 and is now trading above $ 3,200. After an increase of 170 billion dollars in a single day, the total market value exceeded 2,050 billion dollars. Additionally, closeouts exceeded $ 400 million, with the highest order being a $ 10 million short position on Bitmex.

If you find this article informative, please share it with your friends and family!

Also read: Ripple Buries SEC in Paperwork in XRP Lawsuit

Source link

Global Medical 5G Market Share Industry Growth, Size, Statistics, Opportunities and Forecast to 2026

The latest research report on 5G medical market Informs the reader of all the important aspects that influence the behavior of the industry, such as the main growth drivers and challenges, to enable stakeholders to make informed decisions for the future. It also includes a comparison of past and current business scenarios to support the study’s forecast. In addition, the document offers a detailed account of the different market segments and recognizes the key areas that promise solid revenues in the years to come.

According to industry experts, the size of the medical 5G market is expected to generate high profits over 2021-2026, registering a XX% CAGR throughout.

Research literature uncovers the impact of the COVID-19 pandemic on this area, with a focus on obstacles such as changes in customer behavior, supply chain flows and imbalances in business operations . It also recommends various approaches that will ensure an upward growth trajectory in the years to come.

Request a copy of this report @ https://www.nwdiamondnotes.com/request-sample/25582

Important5G Medical Market report pointers:

  • COVID-19 Status and Its Impact on Industry Compensation
  • Market and submarkets growth rate approximations
  • Predominant trends in the vertical
  • Business expansion opportunities
  • Advantages and disadvantages of the indirect and direct sales channel
  • The main traders, suppliers and resellers

Medical 5G Market Segments Covered In The Report:

Geographic bifurcation: North America, Europe, Asia-Pacific, South America and Middle East & Africa

  • Review of the business landscape for each regional market at country level
  • Aggregate sales and revenue data for each area
  • Share of industry captured by major regional contributors
  • Estimates of the growth rate of each regional market over the evaluation period

Product types: IaaS, SaaS, PaaS and others

  • Sales, revenue and market share of each product segment
  • The pricing model for each product category

Application spectrum: Hospital and Clinic

  • Global turnover and sales secured by each application segment
  • Product pricing according to scope

Competitive dashboard:

  • Nokia
  • Samsung Electronics
  • Huawei
  • Ericsson
  • Cisco
  • IBM (Red Hat)
  • Microsoft
  • Juniper networks
  • Accent
  • Oracle
  • NEC and ZTE

  • Products and services offered by the best companies
  • Leading organizations manufacturing facilities in the geographies served
  • Annals of price models, gross margins, sales, market share and cumulative revenue of major players
  • SWOT analysis of the main organizations
  • New emerging competitors in the market
  • Review of well-known trading tactics
  • Conclusive overview of market concentration rate and commercialization rate

Objective of medical 5G: –

To assess the value, market share, sales margin, status of 5G medical industry (2016-2020) and forecast scenario (2021-2026).

Study the main players in medical 5G and their company profiles, production, consumption and import-export statistics

To analyze the growth, opportunity, development and risk of the 5G Medical industry market across various regions.

To understand the competitive view of the market, SWOT and gross margin statistics.

To introduce, describe, analyze, and define the 5G Medical Industry based on product type, applications, and regions.

Examine the development plans, industry policies, market size, value and sales of major players in 5G medical.

Investigate crucial factors such as market risks, drivers, medical 5G maturity analysis.

Table of contents overview:

  1. Overview of the 5G medical market
  2. 5G Medical Market Company Profiles
  3. Competition in the market, by players
  4. Market Size Segment by Type
  5. Market Size Segment by Application
  6. North America by Country, Type and Application
  7. Europe by country, type and application
  8. Asia-Pacific by Region, Type and Application
  9. South America by Country, Type and Application
  10. Middle East & Africa by Country, Type and Application
  11. Research results and conclusion.

Request customization on this report @ https://www.nwdiamondnotes.com/request-for-customization/25582

Source link

As AvePoint, Inc.’s (NASDAQ: AVPT) market cap drops to US $ 1.5 billion, insiders may question their decision to buy earlier this year

Insiders who acquired for $ 3.4 million AvePoint, Inc. (NASDAQ: AVPT) at an average price of $ 9.76 over the past 12 months may be dismayed by the recent price decline of 6.7%. Insiders invest in the hope that their money will increase in value over time. However, due to recent losses, their initial investment is now only worth $ 2.9 million, which is not what they expected.

While we don’t think shareholders should just follow insider trading, we think it makes perfect sense to keep tabs on what insiders are doing.

See our latest review for AvePoint

AvePoint Insider Transactions in the Past Year

Over the past year, we can see that the biggest insider buy was made by independent director Chi On Ho for $ 2.0 million shares, at around $ 10.00 per share. This means that even when the stock price was above US $ 8.39 (the recent price), an insider wanted to buy stocks. Their perspective may have changed since, but it at least shows that they were feeling optimistic at the time. We always take careful note of the price insiders pay when they buy stocks. Typically, we are more positive about a stock if insiders bought stocks at prices higher than current prices, as this suggests that they viewed the stock as good value, even at a low price. higher.

AvePoint insiders may have bought shares in the past year, but they haven’t sold any. You can see insider trading (by companies and individuals) over the past year illustrated in the graph below. By clicking on the graph below, you can see the precise detail of each insider trade!

NasdaqGS: AVPT Insider Trading Volume October 2, 2021

There are always a lot of stocks that insiders buy. So if it suits your style, you can check each stock one by one or you can take a look at this free list of companies. (Hint: insiders buy them).

AvePoint insiders bought shares recently

It’s good to see that AvePoint insiders have made some notable investments in the shares of the company. Not only were there no sales that we can see, but they collectively bought $ 1.4 million worth of stock. It makes you think the company has good points.

AvePoint Insider Ownership

Many investors like to check how well a company is owned by insiders. Strong insider ownership often makes company management more concerned with the interests of shareholders. It’s great to see that AvePoint insiders own 33% of the company, worth around $ 499 million. Most shareholders would be happy to see this type of insider ownership, as it suggests that management’s incentives are well aligned with those of other shareholders.

So what does this data suggest about AvePoint insiders?

It’s good to see recent purchases. We also trust the longer term image of insider trading. However, we note that the company has not made a profit in the past twelve months, which makes us cautious. Once you factor in the high number of Insider Owners, it sure looks like insiders are positive about AvePoint. Attractive! While we love to know what’s going on with insider ownership and trading, we also make sure to consider the risks a stock faces before making any investment decisions. Concrete example: we have spotted 3 warning signs for AvePoint you need to be aware of it, and one of them is potentially serious.

If you would rather consult with another company – one with potentially superior finances – then don’t miss this free list of interesting companies, which have a HIGH return on equity and low leverage.

For the purposes of this article, insiders are those persons who report their transactions to the relevant regulatory body. We currently account for open market transactions and private assignments, but not derivative transactions.

This Simply Wall St article is general in nature. We provide commentary based on historical data and analyst forecasts using only unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell shares and does not take into account your goals or your financial situation. Our aim is to bring you long-term, targeted analysis based on fundamental data. Note that our analysis may not take into account the latest announcements from price sensitive companies or qualitative documents. Simply Wall St has no position in the mentioned stocks.

Do you have any feedback on this item? Are you worried about the content? Get in touch with us directly. You can also send an email to the editorial team (at) simplywallst.com.

If you decide to trade AvePoint, use the cheapest platform * which is ranked # 1 overall by Barron’s, Interactive brokers. Trade stocks, options, futures, currencies, bonds and funds in 135 markets, all from one integrated account.Promoted

Source link

The FTX marketplace to support the famous Solana NFT projects

BeInCrypto –

Major crypto derivatives are exchanging FTX tweets about plans to support famous Solana NFT projects, such as Degen Ape Academy, Aurory, Thugbirdz and Solana Monkey Business.

FTX recently announced via a cryptic tweet that it now supports a range of Solana NFT projects in its cross-channel NFT marketplace, including Degen Ape Academy, a collection of different cartoon monkeys and the new galactic Geckos. FTX announcement the new NFT exchange earlier this year, called SOLSEA. FTX chooses to support NFT projects based on market capitalization, floor price and volume. Support for Opensea NFT collections such as Art Blocks and Bored Yacht Monkey Club should also be supported soon. The Bored Ape Yacht Club is a collection of over 10,000 monkey avatars, hosted on the Ethereum blockchain, built on the ERC-721 Token standard.

Buy and sell on the FTX NFT platform

FTX announced the new NFT market earlier this year, called SOLSEA. Users will be able to Register now on the FTX.US domain, according to FTX.US president Brett Harrison. Deposits and withdrawals, which will only be available on the FTX.US domain, will allow users to deposit external NFTs from peer-to-peer platforms like Opensea or Solanart on the FTX marketplace. It is expected, although unofficial, that escrows, ETH and SOL can also be used to buy and sell NFTs on the FTX market. A fee is charged up front to create an NFT to combat bogus bids, and FTX charges the buyer and seller 5% each for each sale.

This story was first seen on BeInCrypto Join our Telegram group and get trading signals, a free trading course and more stories like this to BeInCrypto

Source link

Venous stents market share to register robust growth through 2026

The Venous Stents market report integrates all the key aspects such as predominant trends and opportunities which will positively impact the industry dynamics during the forecast period. In addition, it contains several recommendations and suggestions for effectively managing the present and future challenges in this vertical industry. Further, the research literature develops the sizes and shares of market segments, including product landscape, application spectrum, and regional terrain. It also highlights the effect of COVID-19 on this area and mentions strategies for effective risk management and high profits in the years to come.

Key points of COVID-19case studies:

  • COVID-19 footprint on social and economic status at regional and global levels.
  • Flows in the supply chain and changes in demand share.
  • Industry scenario before and after the pandemic.

Overview of the regional assessment:

  • Major regional markets are North America, Europe, Asia-Pacific, South America, Middle East & Africa, Southeast Asia.
  • The contribution of each region to the overall growth of the market is taken into consideration.
  • The growth rate, sales and revenue for each area are provided.

Request a copy of this report @ https://www.nwdiamondnotes.com/request-sample/25410

Other Vital Inclusions in the Venous Stents Market Report:

  • The report segments the product type of the venous stents market into Lliac Vein Stent technology, Wallstent technology, and others.
  • Industry share and revenue for each product type are shown.
  • Critical information on the production market growth, patterns and annual growth rate of each product category during the analysis period is also documented.
  • The application spectrum of Venous Stent Graft Market is divided into Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis / Arteriovenous Fistulas, and others.
  • Estimates of the growth rate and market share of each application segment during the forecast period are accompanied by statistics to support the forecast.
  • The main competitors in the venous stent market are Gore Medical, Optimed Medizinische Instrumente GmBH., R. Bard, Inc., Cook Medical, Jotec GmBH and Boston Scientific.
  • The companies mentioned are rated in terms of important parameters such as market remuneration, gross margins, pricing model and production capacity.
  • The report examines key trends and their impact on businesses in order to better understand the competitive dynamics in this vertical.
  • An in-depth industry supply chain assessment is conducted uncovering key manufacturers, raw material and equipment suppliers, and downstream customers.
  • The paper also infers the viability of investing a new project using several methods such as Porter’s Five Force Analysis and SWOT Assessment.

This Venous Stents market research / analysis report contains answers to your following questions:

  • Who are the major global players in this venous stents market? What is their company profile, product information, contact details?
  • What was the global market status of the market? What was the capacity, production value, cost and profit of the market?
  • What are the projections of the global industry taking into account the capacity, output and production value? What will the cost and profit estimate be? What will be the market share, supply and consumption? What about imports and exports?
  • What is the market chain analysis by upstream commodity and downstream industry?
  • What are the market dynamics of the market? What are the challenges and opportunities?
  • What should be the entry strategies, the countermeasures to the economic impact, the marketing channels for the industry?

The scope of the report:

The report offers a comprehensive company profile of key players competing in the global market. Venous Stents Market with special emphasis on share, gross margin, net profit, sales, product portfolio, new applications, recent developments and several other factors. It also sheds light on the vendor landscape to help players realize future competitive changes in the global venous stents market.

Reasons to buy the report:

  • Improve your market research resources with this comprehensive and accurate report on the Global Venous Stents Market
  • Get a full understanding of general market scenarios and future market situations to prepare you for challenges and ensure strong growth
  • The report offers in-depth research and various trends of the Global Venous Stent Graft Market
  • It provides a detailed analysis of changing market trends, current and future technologies used, and various strategies adopted by major players in the global Venous Stents Market
  • It offers recommendations and guidance for new entrants to the global Venous Stent Graft market and carefully guides established players for future market growth.
  • Besides the most advanced technological advancements in the global venous stent market, it sheds light on the plans of the dominant players in the industry


  • Chapter 1 Industry Overview
  • Chapter 2 Production Market Analysis
  • Chapter 3 Sales Market Analysis
  • Chapter 4 Consumer Market Analysis
  • Chapter 5 Production, Sales and Consumption Market Benchmarking
  • Chapter 6 Major Manufacturers Production and Sales Market Benchmarking
  • Chapter 7 Major Product Analysis
  • Chapter 8 Analysis of Major Applications
  • Chapter 9 Industry Chain Analysis
  • Chapter 10 Global and Regional Market Forecast
  • Chapter 11 Major Manufacturers Analysis
  • Chapter 12 Feasibility Analysis of a New Investment Project
  • Chapter 13 Conclusions
  • Chapter 14 Appendix

Request customization on this report @ https://www.nwdiamondnotes.com/request-for-customization/25410

Source link

Artists And Fleas Weekend Marketplace arrives at Ponce City Market in Atlanta – CBS Atlanta

ATLANTA, Georgia (CW69 News at 10) – Ponce city market shoppers can expect more options on October 2, 2021. The Artist and Flea Weekend Market will bring together dozens of collectors, artists and designers.

Peppajar is one of the vendors and the owner, Gwotah Kroma, designs children’s clothing that showcases her West African roots. “There are rompers, scarves, hoodies, all those cute little things for kids that parents can buy,” she said. She started her business three years ago in Atlanta before expanding to California. “I grew up north of Atlanta, I went to Georgia Tech, so Atlanta is the reason I’m home away from home,” Kroma said.

She will join the other vendors who will welcome with open arms all the pedestrian traffic along the beltline. “The inspiration for this was then and always will be to create a place where like-minded designers, makers, artists, vintage collectors can come together,” said Ronen Glimer, who co-founded Artists and Fleas almost 20 years ago. “We see from our existing markets in New York and on the West Coast where people travel and where they travel from, and I think there is so much energy, so much talent, so much creativity that comes from. Atlanta. They are happy to support local vendors and businesses and welcome those who wish to settle down.

Artists and Bullets eagerly awaits weekend shoppers during the holidays. For more details, click here.

Source link

Electric vehicle market share is growing rapidly

We’ve told you about the struggles in the auto industry lately – microchip shortages, supply chain issues – but despite all of this, sales of electric cars keep growing.

Electric vehicles accounted for nearly 5% of light vehicle sales in the United States in July, according to consulting firm Atlas Public Policy. This is almost double the sales of the previous July.

Tesla still dominates the market, but Ford told us this week that it is opening electric vehicle factories in Kentucky and Tennessee. Then there are the buyer incentives and infrastructure financing in the budget reconciliation bill in Congress.

Let’s not lose sight here: sales of electric vehicles, excluding hybrids, still only represent a little over 2% of sales. But their growth is strong.

There are a number of reasons for this, such as climate policy and industry investment, but ultimately automakers are responding to market demands, said. Chris Harto at Consumer Reports.

“Until about a year ago, if you wanted an electric vehicle that cost less than $ 50,000, all your options were compact cars,” Harto said. This class size, he said, is not very popular, even for cars with combustion engines.

Over time, Tesla had competition, while Volkswagen and General Motors introduced cheaper SUVs. And Ford said he has 120,000 pre-orders for its EV F-150 truck, scheduled for launch next spring.

“We are really seeing an explosion in consumer choice, and it’s only just beginning,” Harto said.

Automobile manufacturers who invest in the variety of electric vehicles are certainly important, but we should not overlook the importance of government policy in the evolution of transportation, said Paul bledsoe, consultant to President Barack Obama’s Department of Energy. He now works for the Progressive Policy Institute think tank.

“Tax incentives are crucial in getting people into the EV driver’s seat,” Bledsoe said.

Congressional Budget Reconciliation Bill Would Add Even More Tax Incentives, Bringing Up Possible Total credit up to $ 12,500.

But despite all these practicalities, this change in the auto industry comes down to what people want, for Stephanie Brinley at the consulting firm IHS Markit.

“Cars always tend to be an emotional buy. There’s a ton of choice out there, so we’re definitely doing a lot of streamlining for what we really want, ”she said.

What some people want right now, she said, is to feel good about the environmental consequences of what they’re driving.

Source link